They found butyrophilin-like-9 (BTNL9) and plasmolipin (PLLP) genes being downregulated in IPF patients compared to controls and suggested that both genes might play protective roles in IPF, reducing immune response, inhibiting ECM production, and enhancing endothelium regeneration [9]. This evidence concerns the gene PLLP and idiopathic pulmonary fibrosis.